Cover Page.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 9, p. NP, doi. 10.1093/neuonc/nor136
- Publication type:
- Article
Works matching IS 15228517 AND DT 2011 AND VI 13 AND IP 9
Results: 17
1
2
Subscription Page.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 9, p. NP, doi. 10.1093/neuonc/nor138
- Publication type:
- Article
3
Risk factors for meningioma in postmenopausal women: results from the Iowa Women's Health Study.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 9, p. 1011, doi. 10.1093/neuonc/nor081
- By:
- Publication type:
- Article
4
Society news.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 9, p. 1047, doi. 10.1093/neuonc/nor127
- Publication type:
- Article
5
Neurocytomas: Long-term experience of a single institution.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 9, p. 943, doi. 10.1093/neuonc/nor074
- By:
- Publication type:
- Article
6
AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 9, p. 983, doi. 10.1093/neuonc/nor072
- By:
- Publication type:
- Article
7
Targeting the GD3 acetylation pathway selectively induces apoptosis in glioblastoma.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 9, p. 950, doi. 10.1093/neuonc/nor108
- By:
- Publication type:
- Article
8
Bevacizumab-induced tumor calcifications as a surrogate marker of outcome in patients with glioblastoma.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 9, p. 1020, doi. 10.1093/neuonc/nor099
- By:
- Publication type:
- Article
9
New impact factor number reflects sustained and enhanced growth.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 9, p. 925, doi. 10.1093/neuonc/nor128
- By:
- Publication type:
- Article
10
Contribution of persistent C-Jun N-terminal kinase activity to the survival of human vestibular schwannoma cells by suppression of accumulation of mitochondrial superoxides.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 9, p. 961, doi. 10.1093/neuonc/nor068
- By:
- Publication type:
- Article
11
Differentiating treatment-induced necrosis from recurrent/progressive brain tumor using nonmodel-based semiquantitative indices derived from dynamic contrast-enhanced T1-weighted MR perfusion.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 9, p. 1037, doi. 10.1093/neuonc/nor075
- By:
- Publication type:
- Article
12
Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 9, p. 974, doi. 10.1093/neuonc/nor077
- By:
- Publication type:
- Article
13
Proteomics of gliomas: Initial biomarker discovery and evolution of technology.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 9, p. 926, doi. 10.1093/neuonc/nor078
- By:
- Publication type:
- Article
14
Editorial Board.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 9, p. NP, doi. 10.1093/neuonc/nor137
- Publication type:
- Article
15
The microtubule stabilizer patupilone (epothilone B) is a potent radiosensitizer in medulloblastoma cells.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 9, p. 1000, doi. 10.1093/neuonc/nor069
- By:
- Publication type:
- Article
16
Infratentorial craniospinal irradiation for von Hippel–Lindau: a retrospective study supporting a new treatment for patients with CNS hemangioblastomas.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 9, p. 1030, doi. 10.1093/neuonc/nor085
- By:
- Publication type:
- Article
17
Contents Page.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 9, p. NP, doi. 10.1093/neuonc/nor135
- Publication type:
- Article